|

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2026-06-10
Est. completion2027-06-10
Eligibility
Age45 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07527143

Summary

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Eligibility

Age: 45 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Self-identified Black individuals ≥ 45 years with an intact uterus
* Assigned female sex at birth
* Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
* Willing to participate in a 45-minute virtual interview

Exclusion Criteria:

* Previous or current diagnosis of endometrial cancer

Conditions2

CancerEndometrial Carcinoma

Locations1 site

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Clinical Trials Referral Office855-776-0015

Find trials near these locations

All trials in Minnesota

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.